Long-Term Obeticholic Acid (OCA) treatment associated with reversal or stabilization of fibrosis/cirrhosis in patients with Primary Biliary Cholangitis (PBC)

被引：5

作者：

Bowlus, C. ^{[1
]}

Pockros, P. ^{[2
]}

Kremer, A. E. ^{[3
]}

Pares, A. ^{[4
]}

Forman, L. ^{[5
]}

Drenth, J. P. ^{[6
]}

Ryder, S. ^{[7
,8
]}

Malecha, E. S. ^{[9
]}

Pencek, R. ^{[9
]}

Iloeje, U. ^{[9
]}

Macconell, L. ^{[9
]}

Shapiro, D. ^{[9
]}

Pierre, B. ^{[10
]}

机构：

[1] Univ Calif Davis, Sacramento, CA 95817 USA

[2] Scripps Clin, La Jolla, CA USA

[3] Friedrich Alexander Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany

[4] Univ Barcelona, Hosp Clin, IDIBAPS, CIBERehd, Barcelona, Spain

[5] Univ Colorado Denver, Sch Med, Aurora, CO USA

[6] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[7] Nottingham Univ Hosp NHS Trust, Natl Inst Hlth Res, NDDBRU, Nottingham, England

[8] Univ Nottingham, Nottingham, England

[9] Intercept Pharmaceut Inc, San Diego, CA USA

[10] Serv Anat Pathol, Clichy, France

来源：

关键词：

D O I：

10.1016/S0168-8278(18)30441-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LBP-014

引用

页码：S111 / S112

页数：2